BofA Securities Upgrades BeiGene Ltd. (ONC) to Buy
BofA Securities analyst David Li upgraded BeiGene Ltd. (NASDAQ: ONC) from Neutral to Buy with a price target of $320.00 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
